VALNEVA (EPA:VLA) | WebDisclosure

Basculer en Français

9797	Companies
196381	Keywords
127397	Articles
104411	Press releases

Home
Companies
VALNEVA

BRIEF

published on 01/09/2026 at 07:05, 25 days 21 hours ago

Valneva s'adresse aux investisseurs lors de la conférence JP Morgan sur les soins de santé

Valneva Vaccin Contre La Maladie De Lyme Réunions Avec Les Investisseurs Conférence JP Morgan Portefeuille De Vaccins
BRIEF

published on 01/09/2026 at 07:05, 25 days 21 hours ago

Valneva Engages Investors at J.P. Morgan Healthcare Conference

Valneva Investor Meetings Lyme Disease Vaccine J.P. Morgan Conference Vaccine Portfolio
PRESS RELEASE

published on 01/09/2026 at 07:00, 25 days 21 hours ago

Valneva rencontrera des investisseurs lors de la J.P. Morgan Healthcare Conference
Valneva SE rencontrera des investisseurs lors de la J.P. Morgan Healthcare Conference à San Francisco pour discuter des avancées de son portefeuille de vaccins et des résultats attendus pour le vaccin contre la maladie de Lyme

Investisseurs Valneva SE Maladie De Lyme Vaccins J.P. Morgan Healthcare Conference
PRESS RELEASE

published on 01/09/2026 at 07:00, 25 days 21 hours ago

Valneva to Meet with Investors during the J.P. Morgan Healthcare Conference
Valneva SE to meet with investors at the J.P. Morgan Healthcare Conference to discuss upcoming catalysts from its clinical development pipeline and commercial portfolio of vaccines. Company specializes in prophylactic vaccines for infectious diseases

Valneva SE Prophylactic Vaccines J.P. Morgan Healthcare Conference Vaccine Company Clinical Development Pipeline
BRIEF

published on 12/31/2025 at 17:50, 1 month 3 days ago

Valneva and Serum Institute End Chikungunya Vaccine Collaboration

Public Health Valneva License Agreement Chikungunya Vaccine Serum Institute
BRIEF

published on 12/31/2025 at 17:50, 1 month 3 days ago

Valneva et le Serum Institute mettent fin à leur collaboration sur le vaccin contre le chikungunya

Valneva Santé Publique Contrat De Licence Vaccin Contre Le Chikungunya Institut Du Sérum
PRESS RELEASE

published on 12/31/2025 at 17:45, 1 month 3 days ago

Valneva and Serum Institute of India Announce Discontinuation of Chikungunya Vaccine License Agreement
Valneva and Serum Institute of India mutually agree to discontinue chikungunya vaccine license. Valneva aims for direct control over supply chain and access to high-risk regions

Valneva License Agreement CEPI Chikungunya Vaccine Serum Institute Of India
BRIEF

published on 12/10/2025 at 17:50, 1 month 24 days ago

Valneva annonce des résultats positifs de phase 2 pour son vaccin contre le chikungunya chez les enfants

Valneva SE Étude De Phase 2 Santé Des Enfants Vaccin Contre Le Chikungunya Sécurité Des Vaccins
BRIEF

published on 12/10/2025 at 17:50, 1 month 24 days ago

Valneva Announces Positive Phase 2 Results for Chikungunya Vaccine in Children

Valneva SE Phase 2 Study Children's Health Chikungunya Vaccine Vaccine Safety
BRIEF

published on 12/10/2025 at 17:50, 1 month 24 days ago

Valneva obtient des résultats positifs en Phase 2 pour le vaccin contre le chikungunya chez les enfants

Valneva Phase 2 Vaccin Chikungunya Innocuité

Accesswire

Published on 02/04/2026 at 02:15, 2 hours 1 minute ago

Future Fuels Announces $2 Million LIFE Flow-Through Offering
Published on 02/04/2026 at 00:00, 4 hours 16 minutes ago

Sintana Energy Inc. Announces VMM-37 Resolution
Published on 02/03/2026 at 23:30, 4 hours 46 minutes ago

FutureGen Industries Retains Market-Making Services
Published on 02/03/2026 at 23:12, 5 hours 4 minutes ago

Appointment of Credit Advisor for Stage 1 Operations
Published on 02/03/2026 at 22:30, 5 hours 46 minutes ago

Green Bridge Announces Closing of Non-Brokered Private Placement for Gross Proceeds of C$4 Million

View all ACCESSWIRE

EQS Group

Published on 02/04/2026 at 02:05, 2 hours 11 minutes ago

Saudi Arabia Preparing for AlUla Emerging Market Economies Conference to be Held February 8-9, 2026
Published on 02/04/2026 at 00:42, 3 hours 34 minutes ago

EQS-Adhoc: Dexus Finance Pty Limited: Appendix 3X - Initial Director's Interest Notice
Published on 02/03/2026 at 20:57, 7 hours 19 minutes ago

EQS-Adhoc: tick Trading Software AG adjusts forecast for the current 2025/2026 fiscal year
Published on 02/03/2026 at 20:36, 7 hours 39 minutes ago

Freelance.com: Agenda de communication financière 2026-2027
Published on 02/03/2026 at 20:05, 8 hours 11 minutes ago

KHUFU'S IN EGYPT NAMED NO.1 AT MIDDLE EAST & NORTH AFRICA'S 50 BEST RESTAURANTS 2026

Les Echos

Published on 02/03/2026 at 19:18, 8 hours 57 minutes ago

Paulic Meunerie - Chiffre d'Affaires 2025
Published on 02/03/2026 at 18:00, 10 hours 16 minutes ago

Mint dépasse ses ambitions annoncées pour 2025 grâce à des succès commerciaux majeurs dans le BtoB
Published on 02/03/2026 at 17:45, 10 hours 31 minutes ago

Informations relatives au nombre total de droits de vote et d’actions
Published on 02/03/2026 at 17:45, 10 hours 31 minutes ago

Revenue growth in 2025 to €11.2m (+5%)
Published on 02/03/2026 at 17:45, 10 hours 31 minutes ago

Chiffre d’affaires 2025 en croissance à 11,2 M€ (+5%)

View all LES ECHOS COMFI WIRE